Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Bachelot T.
•
Ciruelos E.
•
Schneeweiss A.
altro
Miles D.
2019